Population Pharmacokinetics of Posaconazole in Immune-Compromised Children and Assessment of Target Attainment in Invasive Fungal Disease

BACKGROUND AND OBJECTIVE: Posaconazole (PSZ) is a triazole antifungal for the management of invasive fungal disease (IFD) in adults and children. Although PSZ is available as an intravenous (IV) solution, oral suspension (OS) and delayed-release tablets (DRTs), OS is the preferred formulation for pe...

Descripción completa

Detalles Bibliográficos
Autores principales: McCann, Sean, Sinha, Jaydeep, Wilson, William S., McKinzie, Cameron J., Garner, Lauren M., Gonzalez, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338595/
https://www.ncbi.nlm.nih.gov/pubmed/37179512
http://dx.doi.org/10.1007/s40262-023-01254-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338595/
https://www.ncbi.nlm.nih.gov/pubmed/37179512
http://dx.doi.org/10.1007/s40262-023-01254-2

Ejemplares similares